In healthy adults, the step length/cadence ratio [walk ratio (WR) in mm/(steps/min) and normalized for height] is known to be constant around 6.5 mm/(step/min). It is a speed-independent index of the overall neuromotor gait control, in as much as it reflects energy expenditure, balance, between-step variability, and attentional demand. The speed independence of the WR in patients with multiple sclerosis (MS), and its capacity to discriminate (a) across patients with MS and controls and (b) among disability levels in MS were tested. The WR was computed in 30 outpatients with MS [20 women, 10 men; Extended Disability Status Scale (potential range: 0-10, observed median 3.5, range 2.5-5.0)] walking at free speed (range: 0.43-1.67 ms), and in 30 healthy controls (20 women, 10 men) at free and slow speed (range: 0.55-1.67 ms). The WR was 6.38±0.66 in controls versus 5.36±0.86 in patients with MS (P<0.000), independent of age, sex, and walking speed. The WR was 5.95±0.69 and 4.90±0.70 in patients with an Extended Disability Status Scale score (P<0.001) below or above the median, respectively, independent of the disease duration (P<0.000). In patients with MS, the WR is a disability-sensitive index of neuromotor control of gait, and thus a promising outcome measure for treatments aimed at improving motor coordination.
Gait analysis (GA) is usually performed during overground walking, with ground reactions being recorded through force platforms embedded in the floor. Body kinematics and surface electromyography (EMG) are also recorded. GA on treadmills resting on force sensors (GAFT) is rather uncommon and has been criticized on various grounds (less reliability of force records; biomechanical differences in walking kinematics and dynamics). On the other hand, the treadmill allows very fast recording of data from many successive strides, at known and constant average speeds. The goals of this study were (a) to validate a system for GAFT based on a commercially available "split-belt" force treadmill, (b) to provide evidence that data can be compared with established norms from overground GA, and (c) to lend support to the potential clinical validity of the GAFT approach. The treadmill adopted here allows subjects to walk on two parallel independent treadmills. Each of them is mounted on four 3D force sensors. Eight healthy adults (four women; ages 22-35 yrs) were tested on the treadmill, each at the average walking speed he or she adopted overground (average across subjects: 1.35 +/- 0.05 m x sec(-1)). Ground reactions, hip, knee, and ankle sagittal rotations, torques, power, and surface EMG from four thigh and leg muscles were recorded simultaneously. Results were compared with those relating to a sample of 40 healthy adults (20 women; manufacturer's data, replicating published data) walking on floor-embedded force platforms (age 20-40 yrs; speed 1.33 +/- 0.06 m x sec(-1)). An 8% shorter stride length was adopted on the treadmill. All of the other results matched those obtainable overground. The results suggest that GAFT performed on the tested treadmill is a promising method of GA in a clinical setting.
1 June 2011 in International Journal of Rehabilitation Research
ABILHAND is, in its original version, a 46-item, 4-level questionnaire. It measures the difficulty perceived by patients with rheumatoid arthritis as they do various daily manual tasks. ABILHAND was originally built through Rasch analysis. In a later study, it was simplified to a generic 23-item, three-level questionnaire, showing both cross-cultural (Belgium vs. Italy) and cross-impairment (rheumatoid arthritis vs. stroke) validity. Later research returned to the development of impairment-specific versions, with modified item sets and levels. Each version has its own Rasch-derived item difficulty calibrations, which are required to extract the patient's measure from the individual string of responses, through computerized algorithms. All of these hamper the practical application of the scale in rehabilitation units, where patients with diverse conditions may share similar impairments and treatment approaches. In this study through Rasch analysis the 'generic' scale was applied to 126 chronic patients with different upper limb impairments, and to 24 healthy controls. It was supported that the generic questionnaire remains valid across a variety of motor impairments. To further facilitate clinical application, a normative cut-off (>79 of 100) is suggested. Rasch-based item calibrations are provided together with a software routine designed to calculate, on individual patients, linear 0-100 measures and error estimates from the raw scores.